A Phase 1a, Double-Blind, Placebo-Controlled, Single Ascending Dose Study to Evaluate Lpathomab in Healthy Volunteers?This study is currently recruiting participants.2015/09/14/ news will coming soon.
Estimated Enrollment: 36 Study Start Date: September 2015 Estimated Study Completion Date: March 2016 Estimated Primary Completion Date: March 2016 (Final data collection date for primary outcome measure)
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.